IBABB Stock Overview
Develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Ion Beam Applications SA Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €18.14 |
| 52 Week High | €18.60 |
| 52 Week Low | €14.36 |
| Beta | 0.76 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 124.78% |
| 5 Year Change | -25.59% |
| Change since IPO | 263.53% |
Recent News & Updates
Recent updates
Shareholder Returns
| IBABB | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | 0% | -0.4% | 2.2% |
| 1Y | n/a | -2.7% | 8.0% |
Return vs Industry: Insufficient data to determine how IBABB performed against the UK Medical Equipment industry.
Return vs Market: Insufficient data to determine how IBABB performed against the UK Market.
Price Volatility
| IBABB volatility | |
|---|---|
| IBABB Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 6.3% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 10.3% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: IBABB has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine IBABB's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1986 | 1,629 | Olivier Legrain | www.iba-worldwide.com |
Ion Beam Applications SA develops, manufactures, and supports medical devices and software solutions for cancer treatments in Belgium, the United States, and internationally. The company operates through Proton Therapy and Other Accelerators, and Dosimetry segments. The Proton Therapy and Other Accelerators segment develops, fabricates, and services medical and industrial particle accelerators, and proton therapy systems.
Ion Beam Applications SA Fundamentals Summary
| IBABB fundamental statistics | |
|---|---|
| Market cap | €477.37m |
| Earnings (TTM) | €6.06m |
| Revenue (TTM) | €361.27m |
78.8x
P/E Ratio1.3x
P/S RatioIs IBABB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| IBABB income statement (TTM) | |
|---|---|
| Revenue | €361.27m |
| Cost of Revenue | €234.51m |
| Gross Profit | €126.77m |
| Other Expenses | €120.71m |
| Earnings | €6.06m |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
Aug 31, 2023
| Earnings per share (EPS) | 0.21 |
| Gross Margin | 35.09% |
| Net Profit Margin | 1.68% |
| Debt/Equity Ratio | 12.4% |
How did IBABB perform over the long term?
See historical performance and comparison